You just read:

Terumo Enhances Coronary Interventional Product Portfolio By Securing Exclusive Global Rights to Orchestra BioMed's Virtue® Sirolimus-Eluting Balloon (SEB) through Global Strategic Partnership

News provided by

Terumo Corporation

Jun 13, 2019, 04:00 ET